Tag: ASX: OIL
Optiscan taps US manufacturer Long Grove Pharmaceuticals for surgical imaging partnership
Optiscan Imaging has entered a five-year collaboration with US drug manufacturer Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein sodium contrast agent used in surgical imaging.
Optiscan advances medical manufacturing with telepathology platform beta test
Optiscan Imaging has completed the beta phase for its cloud-connected telepathology platform, developed in partnership with Prolucid Technologies.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
